logo

Cancer

   
   
 

details of all the experts

Dr Andrew Haynes

Description
Lymphoma trials, bone marrow transplantation and research into drug resistance. Molecular pathology - research and diagnostic.

Dr Charles Laughton

Description
Computational chemistry. Understanding the structures and dynamics of proteins and SNA and how this relates to their function. Medicinal chemistry, particularly the design and development of new anti-cancer agents.

Dr David Morgan

Description
Breast cancer. Head and neck cancer.

Dr Felicity Rose

Description
Stem cells work, particularly in gastrointestinal tissues. Scaffold design and materials for tissue engineering, establishing in vitro models including cancer and GI models and drug delivery devices for wound repair, with a focus on the cornea. Bioreactor design and imaging for 3D tissue growth.

Dr Fiona Bath-Hextall

Description
Evidence-based medicine - systematic reviews and clinical trials. Non melanoma skin cancer.

Dr Helen Byrne

Description
Mathematical medicine - mathematical modelling; solid tumour growth.

Dr Martin Garnett

Description
Expertise in various types of drug delivery, including nanoparticles, polymer-drug conjugates, targeting drugs using monoclonal antibodies and non-viral gene therapy. These drug delivery methods could be applied to a variety of diseases, but are most likely to be useful for cancer treatment.

Dr Neil Thomas

Description
Anti-cancer drugs targeting. Development of anti-tuberculosis drugs. Protein engineering and creation of antibody mimics. Biological catalysis and its applications to chemistry and medicine. Development of new bioluminescence and fluorescence enzyme assays. Development of new nucleic acid aptamers as antibody substitutes.

Dr Paul Garrud

Description
Communication of health risks. Multimedia and patient information/ education. Skin protective behaviours.

Dr Stewart Martin

Description
Novel therapies for treatment of breast, melanoma and ovarian cancer, with focus on new anti-cancer chemotherapy agents used alone and in combination with radiotherapy. Markers expressed in patient samples that may predict their response to therapy. Blood vessel growth in tumours. Tumour growth and spread (metastasis) and strategies to prevent.

Professor Cris Glazebrook

Description
Psychological impact of IVF treatment. Children's understanding of health and illness. Sun protective behaviours.

Professor David Walker

Description
Childhood cancer. Leukaemia. Brain tumours. Measurement of child health outcomes.

Professor John Scholefield

Description
Colorectal cancer. Screening for CRC. Haemorrhoids. Fissures. Crohn's disease.

Professor Karen Cox

Description
Patient involvement in clinical trials in cancer.

Professor Nigel Russell

Description
Leukaemia. Bone marrow transplantation. Myeloma.

Professor Peter E Shaw

Description
Cancer genes. Gene control. Proteomics. Cell signalling.

Professor Peter M Fischer

Description
Drug discovery and development for therapeutic areas including oncology, infection and immunity, metabolic diseases, neurodegenerative diseases.

Professor Poulam Patel

Description
Kidney cancer, malignant melanoma, cancer vaccines.

Professor Richard Grundy

Description
Paediatric cancer and brain tumours. Biology, treatment and outcomes.

Professor Simon Langley-Evans

Description
Human nutrition and disease; coronary heart disease; renal disease; cancer; periodontal disease. Role of nutrition in pregnancy in determining risk of disease in later life. Diet, antioxidents and disease. Diet in pregnancy. Infant nutrition. Fetal development. Diet and obesity.

News and Media - Marketing, Communications and Recruitment

The University of Nottingham
C Floor, Pope Building (Room C4)
University Park
Nottingham, NG7 2RD

telephone: +44 (0) 115 951 5765
email: communications@nottingham.ac.uk